News Cell...

#1 27-01-2009, 16.28.07

Phonata da oltre oceano ore 16:25...
.....ma non lo dico nemmeno sotto tortura...

#2 27-01-2009, 16.36.57

"Max" <peter2006@fastwebnet.it> ha scritto nel messaggio
news:2KFfl.9476$8Z.117@tornado.fastwebnet.it...
> Phonata da oltre oceano ore 16:25...
> ....ma non lo dico nemmeno sotto tortura...

water table subito ...

#3 27-01-2009, 16.56.53

"Max" <peter2006@fastwebnet.it> ha scritto nel messaggio
news:2KFfl.9476$8Z.117@tornado.fastwebnet.it...
> Phonata da oltre oceano ore 16:25...
> ....ma non lo dico nemmeno sotto tortura...

Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis
to Begin Rolling NDA Submission
Tuesday January 27, 1:30 am ET

SEATTLE, Jan. 27 /PRNewswire-FirstCall/ -- Cell Therapeutics (CTI) (Nasdaq
and MTA: CTIC) announced today that after communication with the Food and
Drug Administration (FDA), CTI expects to begin submission of a rolling New
Drug Application (NDA) and request priority review for pixantrone to treat
relapsed aggressive non-Hodgkin's lymphoma (NHL) in the first quarter of
2009. If granted priority review a decision on the NDA could occur before
the end of 2009.
This communication from the FDA is a significant milestone for the Company
and for patients with relapsed aggressive NHL as this could be the first
drug approved for this unmet medical need," noted James A. Bianco, M.D.
Chief Executive Officer of CTI. "With the potential for three drug approvals
in 2009 we are on track to meet our objective of cash flow break even in the
fourth quarter of this year."
The EXTEND clinical trial was a phase III single-agent trial of pixantrone
for patients with relapsed, aggressive non-Hodgkin's lymphoma who received
two or more prior therapies and who were sensitive to treatment with
anthracyclines. The trial enrolled 140 patients and patients were randomized
to receive either pixantrone or another single-agent drug currently used for
the treatment of this patient population and selected by the physician.

#4 27-01-2009, 17.06.44

EH EH EH EH.....Questo è quello da far sapere ai comuni mortali.

.......MOLTO, MA MOOOOOOLTO DI PIU'.....

"magomerlino" <okispamthassos@iol.it> ha scritto nel messaggio
news:99Gfl.166878$Ca.30038@twister2.libero.it...
> "Max" <peter2006@fastwebnet.it> ha scritto nel messaggio
> news:2KFfl.9476$8Z.117@tornado.fastwebnet.it...
>> Phonata da oltre oceano ore 16:25...
>> ....ma non lo dico nemmeno sotto tortura...
>> Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis
> to Begin Rolling NDA Submission
> Tuesday January 27, 1:30 am ET
> SEATTLE, Jan. 27 /PRNewswire-FirstCall/ -- Cell Therapeutics (CTI) (Nasdaq
> and MTA: CTIC) announced today that after communication with the Food and
> Drug Administration (FDA), CTI expects to begin submission of a rolling
> New Drug Application (NDA) and request priority review for pixantrone to
> treat relapsed aggressive non-Hodgkin's lymphoma (NHL) in the first
> quarter of 2009. If granted priority review a decision on the NDA could
> occur before the end of 2009.
> This communication from the FDA is a significant milestone for the Company
> and for patients with relapsed aggressive NHL as this could be the first
> drug approved for this unmet medical need," noted James A. Bianco, M.D.
> Chief Executive Officer of CTI. "With the potential for three drug
> approvals in 2009 we are on track to meet our objective of cash flow break
> even in the fourth quarter of this year."
> The EXTEND clinical trial was a phase III single-agent trial of pixantrone
> for patients with relapsed, aggressive non-Hodgkin's lymphoma who received
> two or more prior therapies and who were sensitive to treatment with
> anthracyclines. The trial enrolled 140 patients and patients were
> randomized to receive either pixantrone or another single-agent drug
> currently used for the treatment of this patient population and selected
> by the physician.

#5 27-01-2009, 17.20.05

Max <peter2006@fastwebnet.it> wrote:

> EH EH EH EH.....Questo è quello da far sapere ai comuni mortali.
> ......MOLTO, MA MOOOOOOLTO DI PIU'.....
ma che voi di oooooooooohhhhhhhhhh!

Facce sapè ......dacce un'anticipo cazzo qì si sta sotto di una cifra!

#6 27-01-2009, 17.22.47

"Max" <peter2006@fastwebnet.it> ha scritto nel messaggio
news:fiGfl.9523$8Z.8609@tornado.fastwebnet.it...
> EH EH EH EH.....Questo è quello da far sapere ai comuni mortali.
> ......MOLTO, MA MOOOOOOLTO DI PIU'.....

........e dai, sbottonati almeno sulla fine che è destinata a fare...muoio
dalla curiosità...

#7 27-01-2009, 17.45.05

Dagli tempo
Pretenderai mica di avere tutto in un giorno.
Inizia a comprarti il costume da bagno.......
(capisci a me.)

"Piemo" <marpiemo@hotmail.it> ha scritto nel messaggio
news:497f34dd$0$746$5fc30a8@news.tiscali.it...
> "Max" <peter2006@fastwebnet.it> ha scritto nel messaggio
> news:fiGfl.9523$8Z.8609@tornado.fastwebnet.it...
>> EH EH EH EH.....Questo è quello da far sapere ai comuni mortali.
>>> ......MOLTO, MA MOOOOOOLTO DI PIU'.....
> .......e dai, sbottonati almeno sulla fine che è destinata a fare...muoio
> dalla curiosità...

#8 27-01-2009, 18.58.58

"Max" <peter2006@fastwebnet.it> ha scritto nel messaggio
news:cSGfl.9571$8Z.6197@tornado.fastwebnet.it...
> Dagli tempo
> Pretenderai mica di avere tutto in un giorno.
> Inizia a comprarti il costume da bagno.......
> (capisci a me.)
dì la verità: tu sei Bianco ....